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Abstract
Computed Tomography Perfusion (CTP) is an imaging modality that generates parametric maps
of cerebral hemodynamics which are useful in the assessment of suspected acute ischemic stoke.
However, the technology underlying CTP is complex and serious controversy surrounds the safety of
CTP tests and the reproducibility and validity of CTP results. This report briefly outlines the history
of CTP, its current clinical applications for stroke management, the main controversies surrounding
CTP, and future directions for this technology.

Introduction
In the setting of acute stroke, knowledge of the
ischemic insult and potential for tissue salvage
is critical in clinical decision-making. Dynamic,
first-pass computed tomography perfusion
(CTP) is an imaging modality that describes the
hemodynamics of cerebral tissues.1 It does so by
gathering information about the flow of contrast
media through the cerebral vasculature and by
calculating perfusion values that describe the
blood flow through cerebral tissue beds. CTP is
rapidly performed,2 commonly accessible,3 and
when used alongside other imaging modalities
such as non-contrast computed tomography
(CT) and CT angiography, improves clinicians’
diagnostic abilities in the setting of acute
cerebrovascular attack.4
But several reports have demonstrated
problems with CTP safety,5 reproducibility,6 and
accuracy,7 which restrict the unique potential
of CTP to produce quantitative perfusion
results that are safely obtained and clinically
meaningful. One factor that has limited the
development of solutions to these problems
may be the general confusion surrounding
the technology, clinical applications, and
controversies in CTP imaging. The purpose of
this review was to briefly describe the history,
current applications, controversies, and future
directions of CTP in the context of acute stroke
management.

History of CTP

Figure 1
Parametric map of Cerebral Blood Flow (CBF). CBF is defined as the volume of blood moving through a given
volume of brain per unit time, with units of milliliters of blood per 100 grams of brain tissue per minute. Regions of
interest are circled and the regional CBF values are calculated and displayed by the software application. Note that
in this image the CBF is dramatically decreased in the left hemisphere, indicating reduced CBF in the territory of the
left middle cerebral artery.
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In 1897 Stewart8 introduced the indicatordilution theory for measurement of cardiac
output and in 1954 Meier and Zierler9 built
upon this work by presenting their theory of the
indicator-dilution method for measurement of
blood flow and volume, which states the basic
relationship that, for a normal physiologic tissue
bed, blood volume equals blood flow times the
mean circulation time (V = F x MT). In 1980
Axel10 first conceptualized the use of Computed
Tomography (CT) in conjunction with a nondiffusible tracer to measure cerebral blood
volume (CBV), cerebral blood flow (CBF), and
mean transit time (MTT). Axel suggested that
the central volume principles set forth by Meier
and Zierler could be applied to CT-acquired
data to successfully generate information about
the blood flow in cerebral tissues.
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The recent development of high-speed helical
or spiral CT scanners provided the machinery
for CTP theory to be translated into practice.3
Furthermore, the development of computer
software applications that process CT source
images and generate perfusion maps enabled
stroke management teams to simply and rapidly
acquire cerebral perfusion data.11 Today, highspeed CT scanners are commonplace in U.S.
hospitals and the entire CTP imaging process
can be performed in a matter of minutes.2

Current applications
At our institution, patients who present with
acute stroke symptoms are managed with a
multi-pronged diagnostic algorithm. The first
diagnostic test is always a non-contrast CT scan
of the brain, which is used to rule-out cerebral
hemorrhage, hematoma, and other lesions.
Secondary tests include CT angiography and
CTP. CT angiography examines the neck and
head vasculature for vessel occlusion or rupture.
This information is used to locate the pathology
and determine whether endovascular treatments, such as thrombectomy, are warranted.
CTP examines ischemic cerebral tissues and
differentiates between irreversibly infarcted
tissue, called the infarct core, and potentially
salvageable tissue, called the penumbra.
It has been argued that infarct core has three
characteristic features: (1) an elevated MTT
(it takes more time for blood to traverse the
ischemic tissue); (2) a reduced CBF (the velocity of blood flow through ischemic tissue is
decreased); and (3) a reduced CBV (the volume
of blood in the ischemic tissue is decreased).3 In

Figure 2
Parametric map of Mean Transit Time (MTT). MTT is defined as the average transit time of blood through a given
brain region, measured in seconds. In this image the MTT is increased in the left hemisphere relative to the right,
indicating a reduced velocity of blood flow in the territory of the left middle cerebral artery.

comparison, penumbra also demonstrates an
elevated MTT and a reduced CBF. However, in
penumbra the CBV is not reduced; it remains
level or may even be elevated, due to collateral

circulation via uninjured arterial and leptomeningeal territories.2 Thus, assuming that
MTT is elevated and CBF is reduced, a mismatch in CBV may determine candidacy for
Figure 3
Computer software
applications use complex
algorithms to generate maps
of irreversibly infarcted
tissue regions (red in this
image) called the infarct
core and theoretically
salvageable tissue regions
(green in this image)
called the penumbra. The
green region in this map
represents a sizeable
region of cerebral tissue
in the left hemisphere
that may benefit from
thrombolytic therapy.
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thrombolytic therapy, with a level or elevated
CBV indicating treatment and a reduced CBV
contraindicating treatment.3

that automation will lead to more appropriate
dosing while others argue that unchecked automation may lead to unnecessary overdosing.5

Penumbra may be salvaged if blood flow
restoration is rapidly achieved. Therapeutic
agents, such as thrombolytics, aid clot
dissolution and are considered when there
is extensive penumbra.2 Yet the decision to
use thrombolytic agents is not without risk
as these medications may also induce severe
hemorrhage. Therefore, the potential benefits
of the recanalization of arteries supplying
injured but salvageable tissue must be weighed
against the potential morbidity and mortality
associated with hemorrhage.3

Another controversy surrounding CTP is
the variability of quantitative results. Studies
have shown that multiple factors affect the
perfusion maps that are generated by software
applications. For example, software operator
differences have led to significantly different
perfusion results.6,15 More recently, differences between software applications have been
shown to generate significantly different results
as well.7 Put differently, it is possible that identical source imaging data for a given patient
will yield significantly different CTP results if
processed by different operators or by different
software applications. For these reasons, quantitative perfusion results have been traditionally
interpreted with caution. Yet there is motive for
improved reproducibility and accuracy of CTP
results, because these values could be used to
develop definitive perfusion thresholds for
use in clinical decision-making, particularly
the use of thrombolytic therapy, such as tissue
plasminogen activator (tPA).16

Stroke management is a complex, teamoriented process. Image source data gathered in
the Emergency Department by the CT scanner
is transmitted over the computer network to
neuroradiologists who process the data using
commercial software applications to generate
CTP parametric maps. These images are
interpreted by neuroradiologists and are also
passed to neurosurgeons. Dialogue between
neuroradiologists,
neurosurgeons,
and
neurologists consider all three studies—noncontrast CT, CT angiography, and CTP—to
arrive at treatment decisions. Of course,
effective communication between members of
the stroke team and efficiency are paramount
in the setting of acute stroke; as the saying goes,
“time is brain.”

Controversies
Several controversies surround CTP, including
the risk of radiation exposure to patients. For
instance, a July 2010 New York Times report5
highlighted the stories of scores of patients
that have recently been exposed to radiation
overdoses during CTP scans in hospitals across
the U.S. On the other hand, the CTP radiation
doses reported in the medical literature have
generally been safe; as one review article stated,
the radiation exposure in a typical CTP scan is
approximately equal to the background radiation a person living in Boston, Massachusetts
is exposed to in a given year.1 The radiation
controversy partially hinges on the balance of
radiation dose with image quality, and several
authors12-14 have explored methods to achieve
adequate image resolution and signal-to-noise
while limiting radiation doses by altering the
image acquisition frequency settings of CT
scanners. This controversy also centers on the
degree of automation that CT scanners use to
calculate radiation doses; some experts argue
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Future directions
The stroke imaging community has identified
two important steps for the improvement of
CTP; standardization of CTP scanning and
standardization of CTP post-processing.17
Progress is being made in both these aims. For
instance, in September, 2007, consensus-based
imaging acquisition protocols (including suggested radiation doses) for CTP were drafted
at an international symposium of experts in
the field.17 Additionally, efforts to improve
the accuracy and reliability of CTP through
the development of a digital phantom data set
against which commercial software platforms
can be evaluated are currently underway.18

Conclusion
CTP is a rapidly developing diagnostic imaging tool that is useful in acute stroke diagnosis.
Standardization of this technology may enable
clinical decision-making based on quantitative data.
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